The most important step in calcium homeostasis is the regulation of parathyroid hormone (PTH) secretion. The discovery and characterization of the calcium sensing receptor (CaR) of the parathyroid cell has led to a better understanding not only of the physiology of the parathyroid glands, but also of the development of hyperparathyroidism. Drugs acting on CaR can now be designed to treat hyperparathyroidism and osteoporosis.
The workshop on primary hyperparathyroidism held at the National Institutes of Health in 2002 has recommended new guidelines for the treatment of asymptomatic hyperparathyroidism. Controversy still exists regarding the treatment of patients with non-classical symptoms, such as weakness, fatigue and depression. Primary hyperparathyroidism as a risk factor for cardiovascular disease and mortality is also debated.
Improved techniques for the preoperative localization of pathological parathyroid glands have led to a shift in surgical strategy: surgeons abandon the traditional bilateral neck exploration in favor of a more limited approach. This change of strategy has not been based on the results of prospective randomized studies and the long term results are not known.
Consensus development conference statement. J Bone Miner Res1991; 6: S9–S13.
2.
BilezikianJPPottsJTJrFuleihanGE-HKleerekoperMNeerRPeacockMRastadJSilverbergSJUdelsmanRWellsSASummary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J Clin Endcrinol Metab2002;87:5353–5361.
3.
BrownEMGambaGRiccardiDLombardiMButtersRKiforOSunAHedigerMALyttonJHebertSCCloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature1993;366:575–580.
4.
BrownEMMacLeodRJExtracellular calcium sensing and extracellular calcium signalling. Physiol Rev2001;81:239–297.
5.
KiforOKiforIBrownEMSignal transduction in the parathyroid. Curr Opin Nephrol Hypertens2002;11:397–402.
6.
VälimäkiSHöögALarssonCFarneboL-OBränströmRHigh extracellular Ca2+ hyperpolarizes human parathyroid cells via Ca(2+)-activated K+ channels. J Biol Chem.2003; 278: 49685–49690.
7.
StewartAFTranslational implications of the parathyroid calcium receptor. N Engl J Med2004;351:324–326.
8.
PollakMRBrownEMChouYHHebertSCMarxSJSteinmannBLeviTSeidmanCESeidmanJGMutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell1993;75:1297–1303.
9.
BrownEMThe pathophysiology of primary hyperparathyroidism. J Bone Miner Res.2002; 17 Suppl 2:N24–29.
10.
PallaisJCKiforOChenY-BSlovikDBrownEMAcquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. New Engl J Med2004;351:362–369.
11.
NemethEFThe search for calcium receptor antagonists (calcilytics). J Mol Endocrinol2002;29:15–21.
12.
GogusevJDuchambonPHoryBGiovanniniMGoureauYSarfatiEDruekeTBDepressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int.1997; 51: 328–336.
13.
FarneboFEnbergUGrimeliusLBackdahlMSchallingMLarssonCFarneboL-OTumor specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab1997;82:3481–3486.
14.
ParfittAMParathyroid growth: Normal and abnormal. In: The parathyroids — Basic and clinical conceptsBilezikianJPLevineMAMarcusR eds. 1994. New York: Raven Press373–405.
15.
ArnoldAThe cyclin D1/PRAD1 oncogene in human neoplasia. J Investig Med1995;43:543–549.
16.
ImanishiYHosokawaYYoshimotoKSchipaniEMallyaSPapanikolaouAKiforOTokuraTSabloskyMLedgardFGronowiczGWangTCSchmidtEVHallCBrownEMBronsonRArnoldAPrimary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest2001;107:1093–1102.
17.
CarptenJDRobbinsCMVillablancaAForsbergLPresciuttiniSBailey-WilsonJSimondsWFGillandersEMKennedyAMChenJDAgarwalSKSoodRJonesMPMosesTYHavenCPetilloDLeotlelaPDHardingBCameronDPannettAAHoogAHeathH3rdJames-NewtonLARobinsonBZarboRJCavacoBMWassifWPerrierNDRosenIBKristofferssonUTurnpennyPDFarneboLOBesserGMJacksonCEMorreauHTrentJMThakkerRVMarxSJTehBTLarssonCHobbsMRHRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet.2002; 32: 676–680.
18.
ShattuckTMVälimäkiSObaraTGazRDClarkOHShobackDWiermannMETojoKRobbinsCMCarptenJDFarneboLOLarssonCArnoldASomatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med2003;349:1722–1729.
19.
BurneyREJonesKRPetersonMChristyBThompsonNWSurgical correction of primary hyperparathyroidism improves quality of life. Surgery1998;124:987–992.
20.
TalposGBBoneHGKleerekoperMPhillipsERAlaMHonasogeMDivineGWRaoDSRandomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: Patient description and effects on the SF-36 health survey. Surgery2000;128:1013–1021.
21.
PasiekaJLParsonsLLDemeureMJWilsonSMalychaPJonesJKrzywdaBPatient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with hyperparathyroidism. World J Surg2002;26:942–949.
22.
MacKLAPasiekaJLAsymptomatic primary hyperparathyroidism: A surgical perspective. Surg Clin N Am2004;84:803–16.
23.
SywakMSKnowltonSTPasiekaJLParsonsLLJonesJDo the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery2002;132:1013–1020.
24.
EigelbergerMSCheahWKItuartePHGStrejaLDuhQYDClarkOHThe NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism — Are they too limited? Ann Surg2004;239:528–535.
25.
PalmérMAdamiHBergströmRÅkerströmGLjunghallSMortality after surgery for primary hyperparathyroidism: A follow-up of 441 patients operated on from 1956 to 1979. Surgery1987;102:1–7.
26.
HedbäckGOdenAIncreased risk of death from primary hyperparathyroidism — An update. Eur J Clin Invest1998;28:271–276.
27.
WermersRAKhoslaSAtkinsonEJGrantCSHodgsonCSO'FallonMMeltonLJSurvival after the diagnosis of hyperparathyroidism: A population based study. Am J Med1998; 104: 115–122.
28.
NilssonILRastadJJohanssonKLindLEndothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery2001;130:986–990.
29.
HagstromELundgrenELithellHBerglundLLjunghallSHellmanPRastadJNormalized dyslipidemia after parathyroidectomy in mild primary hyperparathyroidism: Population-based study over five years. Clin Endocrinol (Oxf)2002;56:253–260.
30.
NilssonILAbergJRastadJLindLCircadian cardiac autonomic nerve dysfunction in primary hyperparathyroidism improves after parathyroidectomy. Surgery2003;134:1013–1019.
31.
SackettWRBarracloughBReeveTSDelbridgeLWWorldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg2002;137:1055–1059.
32.
DenhamDWNormanJCost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg1998;186:293–304.
33.
UdelsmanRSix hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg2002;235:665–672.
34.
HenryJFIacoboneMMirallieEDevezeAPiliSIndications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism. Surgery2001;130:999–1004.
35.
LorenzKMiccoliPMonchikJMDürenMDralleHMinimally invasive video-assisted parathyroidectomy: Multiinstitutional study. World J Surgery2001;25:704–707.
36.
RussellCUnilateral neck exploration for primary hyperparathyroidism. Surg Clin N Am2004;84:705–716.
37.
GotthardtMLohmannBBehrTMBauhoferAFranziusCSchipperMLWagnerMHoffkenHSitterHRothmundMJosephKNiesCClinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: Discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surgery2004;28:100–107.
38.
HaberRSKimCKInabnetWBUltrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: Comparison with 99-m-technetium sestamibi scintigraphy. Clin Endocrinol2002;57:241–249.
39.
ReeveTSBabidgeWJParkynRFEdisAJDelbridgeLWDevittPGMaddernGJMinimally invasive surgery for primary hyperparathyroidism. Arch Surg2000;135:481–487.
40.
MiccoliPBendinelliCBertiPVignaliEPincheraAMarcocciCVideo-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: A prospective randomized study. Surgery1999;126:1117–1121.
41.
LeeNCNortonJAMultiple-gland disease in primary hyperparathyroidism. Arch Surg2002; 137: 896: 900.
42.
GencHMoritaEPerrierNDMiuraDItuartePDuhQYClarkOHDiffering histologic findings after bilateral and focused parathyroidectomy. J Am Coll Surg2003;196:535–540.
43.
GaugerPGAgarwalGEnglandBGDelbridgeLWMatzKAWilkinsonMRobinsonBGThompsonNWIntraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: A 2-institution experience. Surgery2001; 130:1005–1010.
44.
ClericiTBrandleMLangeJDohertyGMGaugerPGImpact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg2004;28:187–192.
